{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:38:44Z","timestamp":1794940724301,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AMC Foundation of the Amsterdam UMC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lymph node metastasis is an important prognostic factor in locally advanced cervical cancer (LACC). No imaging method can successfully detect all\u00a0(micro)metastases. This may result in (lymph node) recurrence after chemoradiation. We hypothesized that lymphatic mapping could identify nodes at risk and if radiation treatment volumes are adapted based on the lymphatic map, (micro)metastases not shown on imaging could be treated. We investigated the feasibility of lymphatic mapping to image lymph nodes at risk for (micro)metastases in LACC and assessed the radiotherapy dose on the nodes at risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with LACC were included between July 2020 and July 2022. Inclusion criteria were:\u2009\u2265\u200918\u00a0years old, intended curative chemoradiotherapy, investigation under anesthesia. Exclusion criteria were: pregnancy and extreme obesity. All patients underwent abdominal MRI, [<jats:sup>18<\/jats:sup>F]FDG-PET\/CT and lymphatic mapping after administration of 6\u20138 depots of <jats:sup>99m<\/jats:sup>Tc]Tc-nanocolloid followed by planar and SPECT\/CT images 2\u20134 and 24\u00a0h post-injection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventeen patients participated. In total, 40 nodes at risk were visualized on the lymphatic map in 13\/17 patients with a median of two [range 0\u20137, IQR 0.5\u20133] nodes per patient, with unilateral drainage in 4\/13 and bilateral drainage in 9\/13 patients. No complications occurred. The lymphatic map showed more nodes compared to suspicious nodes on MRI or [<jats:sup>18<\/jats:sup>F]FDG-PET\/CT in 8\/14 patients. Sixteen patients were treated with radiotherapy with 34 visualized nodes on the lymphatic map. Of these nodes, 20\/34 (58.8%) received suboptimal radiotherapy: 7\/34 nodes did not receive radiotherapy at all, and 13\/34 received external beam radiotherapy (EBRT), but no simultaneous integrated boost (SIB).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Lymphatic mapping is feasible in LACC. Almost 60% of nodes at risk received suboptimal treatment during chemoradiation. As treatment failure could be caused by (micro)metastasis in some of these nodes, including nodes at risk in the radiotherapy treatment volume could improve radiotherapy treatment outcome in LACC.<\/jats:p>\n                <jats:p><jats:italic>Trail registration<\/jats:italic> The study was first registered at the International Clinical Trial Registry Platform (ICTRP) under number of NL9323  on 4 March 2021. Considering the source platform was not operational anymore, the study was retrospectively registered again on February 27, 2023 at CilicalTrials.gov under number of NCT05746156.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13550-023-00989-0","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:01:58Z","timestamp":1686567718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lymphatic mapping for image-guided radiotherapy in patients with locally advanced uterine cervical cancer: a feasibility study"],"prefix":"10.1186","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05746156","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8899-8087","authenticated-orcid":false,"given":"Judit A.","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-5129","authenticated-orcid":false,"given":"Edwin","family":"Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-4332","authenticated-orcid":false,"given":"Berthe L. F.","family":"van Eck-Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-2031","authenticated-orcid":false,"given":"Constantijne H.","family":"Mom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-0295","authenticated-orcid":false,"given":"Lukas J. A.","family":"Stalpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-3784","authenticated-orcid":false,"given":"Jaap","family":"Stoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-2359","authenticated-orcid":false,"given":"Shandra","family":"Bipat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"989_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"989_CR2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1136\/ijgc-2022-003801","volume":"32","author":"BJ Monk","year":"2022","unstructured":"Monk BJ, Tan DSP, Hernandez Chagui JD, Takyar J, Paskow MJ, Nunes AT, et al. Proportions and incidence of locally advanced cervical cancer: a global systematic literature review. Int J Gynecol Cancer. 2022;32:1531\u20139. https:\/\/doi.org\/10.1136\/ijgc-2022-003801.","journal-title":"Int J Gynecol Cancer"},{"key":"989_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijgo.12749","volume":"145","author":"N Bhatla","year":"2019","unstructured":"Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019;145:129\u201335. https:\/\/doi.org\/10.1002\/ijgo.12749.","journal-title":"Int J Gynaecol Obstet"},{"key":"989_CR4","doi-asserted-by":"publisher","unstructured":"Corrigendum to \"Revised FIGO staging for carcinoma of the cervix uteri\" [Int J Gynecol Obstet 145(2019) 129\u2013135]. Int J Gynaecol Obstet. 2019;147:279\u201380. https:\/\/doi.org\/10.1002\/ijgo.12969.","DOI":"10.1002\/ijgo.12969"},{"key":"989_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","volume":"3","author":"S Woo","year":"2020","unstructured":"Woo S, Panebianco V, Narumi Y, Del Giudice F, Muglia VF, Takeuchi M, et al. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Oncol. 2020;3:306\u201315. https:\/\/doi.org\/10.1016\/j.euo.2020.02.007.","journal-title":"Eur Urol Oncol"},{"key":"989_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.08.021","author":"JA Adam","year":"2020","unstructured":"Adam JA, van Diepen PR, Mom CH, Stoker J, van Eck-Smit BLF, Bipat S. [(18)F]FDG-PET or PET\/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: a systematic review of the literature. Gynecol Oncol. 2020. https:\/\/doi.org\/10.1016\/j.ygyno.2020.08.021.","journal-title":"Gynecol Oncol"},{"key":"989_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","volume":"28","author":"D Cibula","year":"2018","unstructured":"Cibula D, Potter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer. 2018;28:641\u201355. https:\/\/doi.org\/10.1097\/IGC.0000000000001216.","journal-title":"Int J Gynecol Cancer"},{"key":"989_CR8","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1200\/JCO.2012.47.3520","volume":"31","author":"S Gouy","year":"2013","unstructured":"Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol. 2013;31:3026\u201333. https:\/\/doi.org\/10.1200\/JCO.2012.47.3520.","journal-title":"J Clin Oncol"},{"key":"989_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ygyno.2021.12.026","volume":"164","author":"AAB Thelissen","year":"2022","unstructured":"Thelissen AAB, Jurgenliemk-Schulz IM, van der Leij F, Peters M, Gerestein CG, Zweemer RP, et al. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2022;164:667\u201374. https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.026.","journal-title":"Gynecol Oncol"},{"key":"989_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1634\/theoncologist.2011-0007","volume":"16","author":"C Uzan","year":"2011","unstructured":"Uzan C, Souadka A, Gouy S, Debaere T, Duclos J, Lumbroso J, et al. Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area. Oncologist. 2011;16:1021\u20137. https:\/\/doi.org\/10.1634\/theoncologist.2011-0007.","journal-title":"Oncologist"},{"key":"989_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","volume":"78","author":"R Potter","year":"2006","unstructured":"Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67\u201377. https:\/\/doi.org\/10.1016\/j.radonc.2005.11.014.","journal-title":"Radiother Oncol"},{"key":"989_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctro.2018.01.001","volume":"9","author":"R Potter","year":"2018","unstructured":"Potter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48\u201360. https:\/\/doi.org\/10.1016\/j.ctro.2018.01.001.","journal-title":"Clin Transl Radiat Oncol"},{"key":"989_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ygyno.2014.02.004","volume":"133","author":"MP Schmid","year":"2014","unstructured":"Schmid MP, Franckena M, Kirchheiner K, Sturdza A, Georg P, Dorr W, et al. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Gynecol Oncol. 2014;133:256\u201362. https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.004.","journal-title":"Gynecol Oncol"},{"key":"989_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.radonc.2018.03.003","volume":"127","author":"D Cibula","year":"2018","unstructured":"Cibula D, Potter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Meder CH, et al. The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol. 2018;127:404\u201316. https:\/\/doi.org\/10.1016\/j.radonc.2018.03.003.","journal-title":"Radiother Oncol"},{"key":"989_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2020.06.034","volume":"137","author":"D Cibula","year":"2020","unstructured":"Cibula D, Kocian R, Plaikner A, Jarkovsky J, Klat J, Zapardiel I, et al. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: the SENTIX trial. Eur J Cancer. 2020;137:69\u201380. https:\/\/doi.org\/10.1016\/j.ejca.2020.06.034.","journal-title":"Eur J Cancer"},{"key":"989_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ygyno.2009.06.017","volume":"115","author":"D Cibula","year":"2009","unstructured":"Cibula D, Kuzel D, Slama J, Fischerova D, Dundr P, Freitag P, et al. Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer. Gynecol Oncol. 2009;115:46\u201350. https:\/\/doi.org\/10.1016\/j.ygyno.2009.06.017.","journal-title":"Gynecol Oncol"},{"key":"989_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/ijgc-2018-000010","volume":"29","author":"D Cibula","year":"2019","unstructured":"Cibula D, Dusek J, Jarkovsky J, Dundr P, Querleu D, van der Zee A, et al. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX). Int J Gynecol Cancer. 2019;29:212\u20135. https:\/\/doi.org\/10.1136\/ijgc-2018-000010.","journal-title":"Int J Gynecol Cancer"},{"key":"989_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2967\/jnumed.119.232199","volume":"61","author":"FJ Hinsenveld","year":"2020","unstructured":"Hinsenveld FJ, Wit EMK, van Leeuwen PJ, Brouwer OR, Donswijk ML, Tillier CN, et al. Prostate-specific membrane antigen PET\/CT combined with sentinel node biopsy for primary lymph node staging in prostate cancer. J Nucl Med. 2020;61:540\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.232199.","journal-title":"J Nucl Med"},{"key":"989_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.euros.2022.12.011","volume":"49","author":"HA de Barros","year":"2023","unstructured":"de Barros HA, Duin JJ, Mulder D, van der Noort V, Noordzij MA, Wit EMK, et al. Sentinel node procedure to select clinically localized prostate cancer patients with occult nodal metastases for whole pelvis radiotherapy. Eur Urol Open Sci. 2023;49:80\u20139. https:\/\/doi.org\/10.1016\/j.euros.2022.12.011.","journal-title":"Eur Urol Open Sci"},{"key":"989_CR20","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1200\/JCO.2010.32.0432","volume":"29","author":"F Lecuru","year":"2011","unstructured":"Lecuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Darai E, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29:1686\u201391. https:\/\/doi.org\/10.1200\/JCO.2010.32.0432.","journal-title":"J Clin Oncol"},{"key":"989_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejca.2021.02.009","volume":"148","author":"P Mathevet","year":"2021","unstructured":"Mathevet P, Lecuru F, Uzan C, Boutitie F, Magaud L, Guyon F, et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2). Eur J Cancer. 2021;148:307\u201315. https:\/\/doi.org\/10.1016\/j.ejca.2021.02.009.","journal-title":"Eur J Cancer"},{"key":"989_CR22","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00259-014-2732-8","volume":"41","author":"F Giammarile","year":"2014","unstructured":"Giammarile F, Bozkurt MF, Cibula D, Pahisa J, Oyen WJ, Paredes P, et al. The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur J Nucl Med Mol Imaging. 2014;41:1463\u201377. https:\/\/doi.org\/10.1007\/s00259-014-2732-8.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00989-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-023-00989-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00989-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:02:09Z","timestamp":1686567729000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-023-00989-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1186\/s13550-023-00989-0","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Amsterdam UMC. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}